Abstract Body

Background: Although antiretroviral therapy (ART) results in sustained inhibition of HIV replication, the virus may continue to replicate at low levels. Moreover, ART has no effect on cells harboring integrated and silenced DNA (“latent reservoir”). A number of retroviral restriction factors have been identified which directly inhibit viral replication in vitro. However, the potential impact of these cell-intrinsic immune factors on viral persistence during ART is unknown. We investigated the relevance of a comprehensive panel of anti-HIV-1 host restriction factors to multiple virologic and immunologic measures of viral persistence in a cohort of 72 HIV-infected, ART-suppressed individuals.

Methods: We measured the expression of 42 anti-HIV-1 host restriction factors, levels of cell-associated HIV-1 RNA, total pol and 2-LTR circle HIV-1 DNA, and immunophenotypes of CD4+ T cells from 72 HIV-1-infected subjects on suppressive ART (23 subjects initiated ART <6 months post-infection, and 49 subjects initiated >1 year post-infection). Data were analyzed using non-parametric tests.

Results: The enhanced expression of three host restriction factors (p21, schlafen 11, and PAF1) was strongly associated with reduced CD4+ T cell-associated HIV RNA during ART (p<0.001). In contrast to previously published data on ART-untreated individuals, the expression of several restriction factors during ART exhibited negative correlations with frequencies of CD4+ T cells expressing markers of T cell activation and exhaustion (CD38, HLA-DR, PD-1) (p<0.01). Cell-intrinsic immune responses were significantly enhanced in subjects who initiated ART during early versus chronic infection (p=0.02).

Conclusions: A few select intrinsic immune responses may modulate HIV persistence during suppressive ART, and therefore may be manipulated to both enhance the efficacy of ART and/or reverse latency in vivo. For example, inhibition of p21, which is known to suppress HIV transcription post-integration, may promote viral reactivation in the setting of the shock and kill eradication framework. Our data also suggest that ART perturbs the regulatory relationship between CD4+ T cell activation and restriction factor expression, which is pertinent to latency reversal agents that activate infected cells. The enhanced intrinsic immune response observed when ART is initiated early provides another possible justification for early administration of ART, and may contribute to the smaller reservoir size noted when ART is initiated early.